EARNINGS DESK$GILDGilead Sciences IncOpen ticker analysis →
Gilead Sciences reported $1.94 a share against $1.78 a share analysts expected for 2026Q3. A beat is the ticket in; guidance and margins decide whether the stock keeps it.
What happened
The company reported $1.94 a share versus an estimate of $1.78 a share, a 9.3% beat.
Revenue was $8.3B against $7.8B expected, 6.4% ahead.
$GILD was at $165.61, up 2.4% in the reference data.
Why it matters
Analysts expect a profit of $1.78 a share, so the bar is about growth and margins rather than survival.
For scale, Gilead Sciences is a large-cap biological products company valued near $197.4B, so it takes serious money to move the stock, which is what makes signals like this one worth tracking.
Earnings and revenue point the same way, which makes the beat cleaner to read.
Implied volatility sits in the 94th percentile of its past year, so options are expensive and the post-earnings drop in volatility can hurt option buyers even when they call the direction right.
Zooming out, $GILD has been in a steady climb, up 6.8% over the past 20 sessions, and it trades above its 20-day average of $152.25, near the top of that range between $142.60 and $160.83.
The numbers
| Report date | 2026-10-29 |
|---|---|
| Timing | After the close |
| Period | 2026Q3 |
| EPS actual | $1.94 |
| EPS estimate | $1.78 |
| EPS surprise | +9.3% |
| Revenue actual | $8.3B |
| Revenue estimate | $7.8B |
| IV percentile | 94th |
| Stock price | $165.61 |
| 39-session range | $142.60, $160.83 |
| 20-day average price | $152.25 |
| 20-session change | +6.8% |
Three ways this could play out
Bullish continuation
Guidance backs up the numbers and $GILD clears $173.89. That puts the stock above its recent range and invites analysts to raise targets.
Bearish rejection
The call raises doubts about the next quarter and $GILD loses $142.60, the bottom of its recent range, turning the report into a reason to sell.
Neutral stabilization
Results land close to expectations and $GILD settles between $142.60 and $173.89 while volatility drains out of the options.
What to watch next
- Guidance for the next quarter and full year, usually the biggest driver of the reaction.
- Margins, which show whether growth is profitable or bought.
- The day-two move. Earnings gaps that hold into the second session tend to stick.
- $142.60 and $160.83: the recent range the reaction has to break.
